Apnimed, Inc. APMD

Set alert

Price alert · APMD

All alert types
15.40 USD -1.00 -6.10%

At close · Nov 2

15.40 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
15.33 × 2
Ask
15.41 × 2
15.09 Day range 16.78
15.09 52-week range 35.29
YTD
-38.40%
1 year
-38.40%
Open
16.55
Prev close
16.40
Mkt cap
641.11M
Vol
530.95K
Avg vol
462.31K
EPS
7.22
P/E
2.13
Div yield
0.00%
More statistics
Low
15.09
High
16.78
Forward P/E
-6.42
Beta
0.00
Short ratio
1.05
Inst. own
18.53%
Dividend
0.00
Ex-div date
50-d avg
27.74
200-d avg
27.74
1y target
50.33

1D chart

Chart tools
Interval

Signals (25)
NameTimeAgo
SMA: Bullish12:17 PM16 hours ago
SMA: Bullish12:10 PM16 hours ago
MACD: Buy Signal12:00 PM17 hours ago
MACD: Sell Signal11:50 AM17 hours ago
SMA: Bullish11:36 AM17 hours ago
RSI: Oversold11:28 AM17 hours ago
MACD: Buy Signal11:24 AM17 hours ago
MACD: Sell Signal10:54 AM18 hours ago
RSI: Oversold10:54 AM18 hours ago
SMA: Bearish10:52 AM18 hours ago
SMA: Bearish10:51 AM18 hours ago
SMA: Bullish10:48 AM18 hours ago
SMA: Bullish10:48 AM18 hours ago
MACD: Buy Signal10:48 AM18 hours ago
MACD: Sell Signal10:34 AM18 hours ago
MACD: Buy Signal10:32 AM18 hours ago
SMA: Bearish10:25 AM18 hours ago
SMA: Bearish10:25 AM18 hours ago
SMA: Bullish10:24 AM18 hours ago
SMA: Bullish10:24 AM18 hours ago

Newest 20 of 25.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 50.33 +226.8% upside
Target (low)
41.00
Target (mean)
50.33
Target (high)
60.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

APMD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.34-0.54 – 0.000.000.0%00.0%3
Next quarter-0.60-0.80 – -0.590.000.0%00.0%2
Current year-0.06-0.06 – -0.060.000.0%90.85M0.0%1
Next year-3.98-5.55 – -1.39-0.06-6525.0%22.44M-75.3%4

Upgrades and downgrades

The latest rating changes

APMD analyst upgrades and downgrades
DateFirmActionFromTo
Aug 25, 2026LifeSci CapitalInitiated—Outperform
Aug 25, 2026Cantor FitzgeraldInitiated—Overweight
Aug 25, 2026Evercore ISI GroupInitiated—Outperform
Aug 25, 2026B of A SecuritiesInitiated—Buy